SCHEMBL6947633

SCHEMBL6947633

Cc1nccn1CCC(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.52
ALDH1A1 P00352 3/20 0.52
KMT2A Q03164 3/20 0.50
HSD11B1 P28845 3/20 0.50
NOS1 P29475 1/20 0.49
CTNNB1 P35222 1/20 0.49
WNT3A P56704 1/20 0.49
ALPL P05186 2/20 0.48
ALPG P10696 2/20 0.48
HTR1A P08908 2/20 0.48
ALPI P09923 1/20 0.48
PLAA Q9Y263 1/20 0.48
GFER P55789 1/20 0.47
POLB P06746 1/20 0.46
TBXAS1 P24557 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948828 0.91 ALDH1A1 (0.51) ESR1ALDH1A1KMT2AHSD11B1NOS1
SCHEMBL11147242 0.88 MMP1 (0.48) ESR1ALDH1A1KMT2ANOS1ALPL
SCHEMBL6943126 0.85 ALDH1A1 (0.50) ALDH1A1KMT2ANOS1ALPLALPG
SCHEMBL4926204 0.84 NOS1 (0.66) KMT2ANOS1ALPLALPGALPI
SCHEMBL6943140 0.83 MAPT (0.56) ALDH1A1KMT2AHSD11B1NOS1ALPL
SCHEMBL11144610 0.81 MMP1 (0.46) ALDH1A1KMT2ANOS1ALPLALPG
SCHEMBL992745 0.80 SMN1; SMN2 (0.61) ESR1ALDH1A1KMT2AALPLALPG
SCHEMBL11152184 0.80 MAPK14 (0.45) ESR1ALDH1A1KMT2ANOS1ALPL
SCHEMBL11441427 0.79 MMP1 (0.49) ALDH1A1KMT2ANOS1ALPLALPG
SCHEMBL6950320 0.77 NPC1 (0.53) ALDH1A1KMT2ANOS1ALPLALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP disclosed
US-5770740-A TREATING DEPRESSION AND OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1998-06-23 US disclosed
US-5696142-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-12-09 US disclosed
US-5686447-A ANTIDEPRESSANTS, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5686483-A TREATING DEPRESSION AND OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5686446-A ANTIDEPRESSANTS, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5684021-A Aminoalkyloximes for treating depression and affective disorders HOECHST MARION ROUSSEL, INC. (US) 1997-11-04 US disclosed
US-5665756-A Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders HOECHST MARION ROUSSEL, INC. (US) 1997-09-09 US disclosed
US-5648367-A ANTIDEPRESANTS, OBSESSIVE-COMPULSIVE DISORDER HOECHST MARION ROUSSEL, INC. (US) 1997-07-15 US disclosed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP disclosed